Inhaled Isoflurane for Sedation of Invasively Ventilated Patients With Cardiogenic Shock on Extracorporeal Membrane Oxygenation
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 300 participants.
Also called NCT07099014
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 300 participants
- Registry
-
NCT07099014 -
2023-510261-94-00
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07099014. Randomized; no masking; primary purpose treatment. Start 2025-09-15 (anticipated); primary completion 2028-10-13 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Inhaled Isoflurane for Sedation of Invasively Ventilated Patients With Cardiogenic Shock on Extracorporeal Membrane Oxygenation
- Acronym
- INSEPTION
- Condition
- Cardiogenic Shock, ECMO
- Intervention (Drug)
- Inahled Isoflurane
- Intervention (Drug)
- Propofol, midazolam
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
Record details
- Record id
cardio:ct-nct07099014- Content hash
3fbc82df01f91c9b1141514a52aa0515ea4621c4fa94ff54756a446563276cfc